Related Experiment Video
Updated: Jun 27, 2026
06:33
Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia
Published on: November 10, 2023
Global gene expression profile in myelodysplastic syndromes using SAGE
C F Mendiburu1, W A Silva, O Ricci
1Departamento de Biologia, Instituto de Biociência Letras e Ciências Exatas, Universidade Estadual de São Paulo, São José do Rio Preto, SP, Brasil. fmendiburu@yahoo.com.ar
Genetics and Molecular Research : GMR
|December 11, 2008
Summary
Researchers explored gene expression in refractory anemia with excess blasts (RAEB), a type of myelodysplastic syndrome (MDS). This study provides insights into the genetic defects underlying MDS, aiding in understanding disease pathology and identifying involved genes.
Area of Science:
- Hematology
- Molecular Biology
- Genomics
Background:
- The molecular pathogenesis of myelodysplastic syndromes (MDS) remains incompletely understood.
- Identifying genetic defects is crucial for understanding MDS.
- Refractory anemia with excess blasts (RAEB) is a subtype of MDS requiring further investigation.
Purpose of the Study:
- To determine the overall profile of genes expressed in bone marrow of RAEB patients.
- To expand knowledge of genetic defects in MDS.
- To identify genes involved in MDS physiopathology.
Main Methods:
- Serial Analysis of Gene Expression (SAGE) was employed.
- Bone marrow samples from RAEB patients were analyzed.
- A partial transcriptome was generated from 56,694 sequenced tags.
Main Results:
- A partial transcriptome of RAEB bone marrow was described.
- Information on expressed gene products in RAEB was obtained.
- This represents the first SAGE-based overall gene expression profile for RAEB at diagnosis.
Conclusions:
- The study provides a valuable gene expression profile for RAEB.
- This data is expected to advance the understanding of MDS physiopathology.
- The findings will aid in identifying genes implicated in MDS development.
